CJ Bioscience, Inc. (KOSDAQ:311690)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,855.00
0.00 (0.00%)
At close: Sep 11, 2026

CJ Bioscience Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
50,367121,770131,831147,076170,481286,048
Market Cap Growth
-61.68%-7.63%-10.37%-13.73%-40.40%43.54%
Enterprise Value
17,29874,17998,118116,989139,502291,080
Last Close Price
3855.009320.0010090.0016140.0024887.5141793.85

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
13.7032.9838.0326.3841.8465.56
PB Ratio
1.212.271.702.063.433.26
P/TBV Ratio
1.682.912.022.493.513.26

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
4.7020.0928.3020.9834.2466.72

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.190.190.120.120.580.27
Net Debt / Equity Ratio
-0.79-0.75-0.85-0.78-0.41-0.64
Net Debt / EBITDA Ratio
1.731.952.202.070.696.58
Net Debt / FCF Ratio
1.671.732.341.860.815.98
Asset Turnover
0.050.040.040.060.040.05
Inventory Turnover
14.6119.5022.2132.5024.9010.67
Quick Ratio
2.763.554.104.381.433.39
Current Ratio
2.883.614.144.431.463.42
Return on Equity (ROE)
-41.76%-36.54%-44.00%-37.82%-50.78%-31.51%
Return on Assets (ROA)
-20.11%-18.02%-22.44%-21.95%-20.00%-6.66%
Return on Capital Employed (ROCE)
-50.50%-42.90%-42.20%-42.00%-58.90%-10.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-44.33%-19.71%-24.91%-15.58%-20.48%-6.74%
FCF Yield
-39.29%-19.24%-21.34%-20.28%-14.73%-3.28%
Buyback Yield / Dilution
-16.13%-40.89%-30.92%-20.52%-38.23%-10.14%